Myocardial infarction (MI) is still the leading cause of mortality worldwide. The success of cell-
based therapies and tissue engineering strategies for treatment of injured myocardium have …

In light of the limited efficacy of current treatments for cardiac regeneration, tissue
engineering approaches have been explored for their potential to provide mechanical …

The purpose of this review is to assess the state-of-the-art fabrication methods, advances in
genome editing, and the use of machine learning to shape the prospective growth in cardiac …

Myocardial infarction (cardiac tissue death) is among the most prevalent causes of death
among the cardiac patients due to the inability of self-repair in cardiac tissues. Myocardial …

Myocardial infarction is the first cause of worldwide mortality, with an increasing incidence
also reported in develo** countries. Over the past decades, preclinical research and …

Molecule self-assembly is a ubiquitous phenomenon and a key driving force for constructing
nanostructures with diverse morphology and controllable size. Recently, interests in …

Myocardial Infarction (MI) is the most common cardiovascular disease. An average-sized MI
causes the loss of up to 1 billion cardiomyocytes and the adult heart lacks the capacity to …

Utilizing polymers in cardiac tissue engineering holds promise for restoring function to the
heart following myocardial infarction, which is associated with grave morbidity and mortality …

Heart failure is a disease of epidemic proportion and a leading cause of mortality in the
world. Because cardiac myocytes are terminally differentiated cells with minimal intrinsic …

The ability of the adult heart to regenerate cardiomyocytes (CMs) lost after injury is limited,
generating interest in develo** efficient cell-based transplantation therapies. Rigid carbon …